Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Covalon Technologies Ltd V.COV

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  CVALF

Covalon Technologies Ltd is engaged in the business of developing, licensing, and selling medical technologies. The Company's segments are Advanced Wound Care and Specialized Medical Device Coatings.
Price: $0.84 | Change: $0.00 | %Change: 0.00%
Volume: 0 | Day High/Low: N/A/N/A | 52 Week High/Low: 1.87/0.57
View modes: 
0 stars

RE:RE:Contract renewed?

I'm wondering if COV will ever sign another licensing deal. it's been 2 yrs since they signed with Molnlycke which of course has since fallen apart. They've been saying for at least more
0 stars


Rumors have it that 3M is close to launching a new antimicrobial dressing and it apparently has a collagen dressing in the works. May be that is why they decided to terminate.   rate and reply
0 stars

RE:Contract renewed?

Are you referring to the licensing agreement with Molnlycke?  From the MD&A: "Molnlycke informed Covalon that Molnlycke does not anticipate being able to meet the annual minimum more
0 stars

Contract renewed?

The contract was expiring Oct 15th i Think Anyone?  rate and reply
0 stars

RE:RE:Why is Covalon not attending the AVA 2015

Zen take a look at Revive Therapeutics... I have been nibbling away this little stock for about 6 months and have a nice little position in it. I like the strategy and I have just been rewarded with more
0 stars

RE:Why is Covalon not attending the AVA 2015

Covalon can't begin marketing a product that they still have under a license agreement, the note in the report said Monlycke does not anticipate meeting the minimums and is negotiating the more
0 stars

Why is Covalon not attending the AVA 2015

Does anyone know why Covalon is not attending AVA 2015? AVA is the big scientific meeting for vascular access. All the potential IV clear partners such as Bard, Hospira, Baxter, Medcomp, BD, more
0 stars

RE:RE:RE:RE:RE:RE:Turnaround seams evident, good strategy 4 further growth IMO

d....thanks for the heads up...I will keep monitoring it, however...I'll wait it out a bit longer.    rate and reply
4.5 stars

RE:RE:RE:RE:RE:Turnaround seams evident, good strategy 4 further growth IMO

G be careful on this one, unless you are willing to be stuck in it for a long while. Like Zen, I thought the company might actually be ready to breakout but they have disappointed again in that more
0 stars

RE:RE:RE:RE:Turnaround seams evident, good strategy 4 further growth IMO

ZEN...good thing I did not buy into COV back in July. So is it now the right time to jump in?    G1945V    rate and reply
0 stars

RE:RE:RE:Molnlycke not meeting minimums

Cardinal, is likely their best option, Bard is unlikely because they have a bit of history with Bard. As you will remember they did a coating deal with Bard about 6 years ago and it did not result more
0 stars

RE:RE:Molnlycke not meeting minimums

Covalon wrote a strong agreement and will get the rights to their technology back, rather than having to let a viable product languish and struggle to get out of the agreement as they had to do more
0 stars

RE:Molnlycke not meeting minimums

It is never a good thing when a major can't move a product they paid upfronts on but Zen could be right on this; as I previously cautioned Molnlycke might not perform beyond minimums because more
0 stars

Molnlycke not meeting minimums

"Molnlycke informed Covalon that Molnlycke does not anticipate being able to meet the annual minimum sales commitment under the license agreement by the anniversary of November 1, 2015. On more
0 stars

RE:small amount insider buying on June 16 - 5000 shares at 1.05

More buying by director - 8000 shares at 80 cents on Aug 28  rate and reply
1 star

New Business Development Manager as of July 2015 could just be a replacement but new staff still being hired over the past 12 months  rate and reply
3 stars

Upcoming conferences SAWC:Sept 26-28, 2015 Arab Health: Jan 25-28, 2016  rate and reply
1 star

RE:Time to buy?

SH; you are correct on the performance of the Company but given the past performance of this Company I am betting there is a trust issue for investors. There are many who invested and were badly more
3 stars

Time to buy?

They added a second facility and increased the number of products by 78% last quarter. They are adding distribution globally. They are holding increased inventories. They reported strong more
1 star

RE:RE:RE:RE:Turnaround seams evident, good strategy 4 further growth IMO

Nibble away.... you will get as much as you want - but don't chase it. There is very little support for the stock as noone is making a market for it so if you are patient you should do fine. more

Stockhouse would like your help. Please click here.